| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 29 | 2009 | 272 | 2.330 |
Why?
|
| Antihypertensive Agents | 16 | 2009 | 85 | 2.060 |
Why?
|
| Echocardiography | 34 | 2015 | 173 | 1.540 |
Why?
|
| Hypertrophy, Left Ventricular | 17 | 2015 | 26 | 1.340 |
Why?
|
| Coronary Disease | 12 | 2004 | 87 | 1.270 |
Why?
|
| Cardiovascular Diseases | 11 | 2016 | 411 | 1.180 |
Why?
|
| Myocardial Infarction | 15 | 2004 | 175 | 1.070 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 5 | 2009 | 27 | 0.680 |
Why?
|
| Ventricular Dysfunction, Left | 8 | 2011 | 42 | 0.640 |
Why?
|
| Humans | 97 | 2016 | 29829 | 0.570 |
Why?
|
| Electrocardiography | 15 | 2014 | 219 | 0.550 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2008 | 64 | 0.540 |
Why?
|
| Heart | 4 | 2015 | 96 | 0.520 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 21 | 0.510 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2015 | 15 | 0.500 |
Why?
|
| Calcium Channel Blockers | 2 | 2006 | 39 | 0.500 |
Why?
|
| Regeneration | 1 | 2015 | 27 | 0.500 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 31 | 0.500 |
Why?
|
| Stem Cell Transplantation | 1 | 2015 | 40 | 0.490 |
Why?
|
| Stroke | 3 | 2010 | 294 | 0.450 |
Why?
|
| Risk Factors | 19 | 2015 | 2466 | 0.440 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2003 | 42 | 0.440 |
Why?
|
| Hypolipidemic Agents | 2 | 2003 | 22 | 0.420 |
Why?
|
| Heart Failure | 7 | 2004 | 207 | 0.410 |
Why?
|
| Heart Ventricles | 15 | 2004 | 168 | 0.380 |
Why?
|
| Ventricular Function, Left | 8 | 2009 | 49 | 0.380 |
Why?
|
| Arrhythmias, Cardiac | 10 | 2003 | 153 | 0.380 |
Why?
|
| Acute Coronary Syndrome | 3 | 2014 | 15 | 0.360 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 30 | 0.330 |
Why?
|
| Ramipril | 1 | 2009 | 1 | 0.330 |
Why?
|
| Benzoates | 1 | 2009 | 6 | 0.330 |
Why?
|
| Benzimidazoles | 1 | 2009 | 11 | 0.320 |
Why?
|
| Diastole | 5 | 2009 | 36 | 0.320 |
Why?
|
| Cardiology | 3 | 2014 | 73 | 0.320 |
Why?
|
| Angina, Unstable | 4 | 2014 | 11 | 0.320 |
Why?
|
| United States | 11 | 2015 | 2344 | 0.310 |
Why?
|
| Blood Pressure | 11 | 2015 | 252 | 0.300 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2008 | 349 | 0.300 |
Why?
|
| Dobutamine | 3 | 1994 | 3 | 0.290 |
Why?
|
| Middle Aged | 43 | 2016 | 9953 | 0.290 |
Why?
|
| Atrial Fibrillation | 2 | 2003 | 186 | 0.280 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 17 | 0.280 |
Why?
|
| Double-Blind Method | 13 | 2004 | 520 | 0.270 |
Why?
|
| Oxazoles | 1 | 2006 | 3 | 0.270 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2006 | 3 | 0.270 |
Why?
|
| Glycine | 1 | 2006 | 12 | 0.260 |
Why?
|
| Coronary Angiography | 9 | 2004 | 91 | 0.260 |
Why?
|
| Drug Approval | 1 | 2006 | 31 | 0.260 |
Why?
|
| United States Food and Drug Administration | 1 | 2006 | 71 | 0.260 |
Why?
|
| Mitral Valve Prolapse | 6 | 1992 | 7 | 0.260 |
Why?
|
| Male | 46 | 2015 | 15858 | 0.250 |
Why?
|
| Female | 45 | 2015 | 16417 | 0.250 |
Why?
|
| Coronary Artery Bypass | 3 | 2014 | 31 | 0.240 |
Why?
|
| American Heart Association | 2 | 2014 | 29 | 0.240 |
Why?
|
| Echocardiography, Doppler | 7 | 2009 | 22 | 0.240 |
Why?
|
| Captopril | 1 | 2004 | 1 | 0.230 |
Why?
|
| Perindopril | 1 | 2004 | 1 | 0.230 |
Why?
|
| Tetrazoles | 1 | 2004 | 3 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2015 | 201 | 0.230 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2004 | 9 | 0.230 |
Why?
|
| Vitamins | 1 | 2004 | 16 | 0.230 |
Why?
|
| Valine | 1 | 2004 | 11 | 0.230 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 3 | 2009 | 4 | 0.230 |
Why?
|
| Cardiomegaly | 6 | 1993 | 12 | 0.230 |
Why?
|
| Verapamil | 1 | 2004 | 38 | 0.230 |
Why?
|
| Indoles | 1 | 2004 | 51 | 0.230 |
Why?
|
| Metoprolol | 2 | 2003 | 8 | 0.220 |
Why?
|
| Exercise Test | 2 | 1994 | 124 | 0.220 |
Why?
|
| Pravastatin | 1 | 2003 | 2 | 0.220 |
Why?
|
| Losartan | 1 | 2003 | 2 | 0.220 |
Why?
|
| Heptanoic Acids | 1 | 2003 | 3 | 0.220 |
Why?
|
| Carbazoles | 1 | 2003 | 6 | 0.220 |
Why?
|
| Propanolamines | 1 | 2003 | 9 | 0.220 |
Why?
|
| Heart Diseases | 6 | 1992 | 75 | 0.220 |
Why?
|
| Pyrroles | 1 | 2003 | 23 | 0.210 |
Why?
|
| Prevalence | 6 | 2010 | 494 | 0.210 |
Why?
|
| Dietary Supplements | 1 | 2003 | 53 | 0.210 |
Why?
|
| Carotid Artery Diseases | 1 | 2003 | 44 | 0.210 |
Why?
|
| Aged | 31 | 2015 | 9633 | 0.210 |
Why?
|
| Antioxidants | 1 | 2003 | 61 | 0.210 |
Why?
|
| Stroke Volume | 3 | 2001 | 61 | 0.200 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2002 | 46 | 0.200 |
Why?
|
| Body Mass Index | 5 | 2015 | 425 | 0.200 |
Why?
|
| Prognosis | 7 | 2015 | 874 | 0.200 |
Why?
|
| Life Style | 3 | 1999 | 212 | 0.190 |
Why?
|
| Follow-Up Studies | 8 | 2015 | 1859 | 0.190 |
Why?
|
| Incidence | 5 | 2015 | 759 | 0.180 |
Why?
|
| Ultrasonography | 8 | 2006 | 224 | 0.180 |
Why?
|
| Treatment Outcome | 6 | 2009 | 3557 | 0.180 |
Why?
|
| Risk Assessment | 6 | 2016 | 683 | 0.180 |
Why?
|
| Metabolic Syndrome | 2 | 2015 | 67 | 0.170 |
Why?
|
| Critical Care | 2 | 2002 | 242 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 401 | 0.170 |
Why?
|
| Primary Prevention | 1 | 1999 | 39 | 0.170 |
Why?
|
| Blood Glucose | 3 | 2011 | 112 | 0.160 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 1997 | 9 | 0.160 |
Why?
|
| Heart Auscultation | 3 | 1988 | 4 | 0.160 |
Why?
|
| Diabetes Mellitus | 4 | 2009 | 140 | 0.150 |
Why?
|
| Heart Atria | 2 | 1996 | 74 | 0.150 |
Why?
|
| Diabetic Angiopathies | 2 | 2015 | 8 | 0.150 |
Why?
|
| Doxazosin | 2 | 1997 | 3 | 0.150 |
Why?
|
| Drug Therapy, Combination | 2 | 2009 | 245 | 0.140 |
Why?
|
| Multicenter Studies as Topic | 3 | 2004 | 77 | 0.140 |
Why?
|
| Coronary Artery Disease | 2 | 2004 | 125 | 0.140 |
Why?
|
| Cardiac Catheterization | 2 | 2001 | 93 | 0.140 |
Why?
|
| Electric Countershock | 1 | 1996 | 32 | 0.140 |
Why?
|
| Hydrochlorothiazide | 1 | 1996 | 1 | 0.140 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 1996 | 1 | 0.140 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 9 | 0.140 |
Why?
|
| Quality of Life | 3 | 2001 | 676 | 0.130 |
Why?
|
| Hemodynamics | 4 | 2001 | 90 | 0.130 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 23 | 0.120 |
Why?
|
| Heart Conduction System | 3 | 2003 | 34 | 0.120 |
Why?
|
| Disease Management | 1 | 2014 | 122 | 0.110 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 802 | 0.110 |
Why?
|
| Sensitivity and Specificity | 6 | 2004 | 558 | 0.110 |
Why?
|
| Thrombosis | 3 | 1997 | 59 | 0.110 |
Why?
|
| Heart Valve Diseases | 2 | 1992 | 23 | 0.110 |
Why?
|
| Heart Injuries | 1 | 1992 | 4 | 0.100 |
Why?
|
| Shock | 1 | 1992 | 9 | 0.100 |
Why?
|
| Myocardium | 1 | 1993 | 145 | 0.100 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1991 | 6 | 0.100 |
Why?
|
| Circadian Rhythm | 4 | 1996 | 283 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 1991 | 17 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 3 | 1996 | 20 | 0.100 |
Why?
|
| Adult | 14 | 2016 | 8731 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2011 | 60 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2015 | 1821 | 0.090 |
Why?
|
| Sex Factors | 5 | 2006 | 497 | 0.090 |
Why?
|
| Indians, North American | 1 | 2010 | 4 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2003 | 40 | 0.090 |
Why?
|
| Animals | 3 | 2006 | 4653 | 0.090 |
Why?
|
| Clinical Trials as Topic | 3 | 1999 | 337 | 0.080 |
Why?
|
| Mitral Valve | 2 | 1988 | 12 | 0.080 |
Why?
|
| Exercise | 3 | 1999 | 474 | 0.080 |
Why?
|
| Global Health | 1 | 2009 | 55 | 0.080 |
Why?
|
| Contrast Media | 2 | 2004 | 125 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2009 | 54 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2003 | 81 | 0.080 |
Why?
|
| Systole | 4 | 2009 | 20 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 455 | 0.080 |
Why?
|
| Tunica Intima | 2 | 2004 | 27 | 0.070 |
Why?
|
| Catecholamines | 3 | 1993 | 13 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2001 | 398 | 0.070 |
Why?
|
| Cerebrovascular Disorders | 2 | 2005 | 139 | 0.070 |
Why?
|
| Intensive Care Units | 3 | 1994 | 312 | 0.070 |
Why?
|
| Anti-Arrhythmia Agents | 4 | 1995 | 110 | 0.070 |
Why?
|
| Socioeconomic Factors | 3 | 2004 | 329 | 0.070 |
Why?
|
| Comorbidity | 4 | 2014 | 504 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2006 | 75 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2001 | 532 | 0.060 |
Why?
|
| Weight Loss | 2 | 1997 | 101 | 0.060 |
Why?
|
| Cohort Studies | 6 | 2011 | 1953 | 0.060 |
Why?
|
| Body Height | 1 | 2005 | 33 | 0.060 |
Why?
|
| Albuminuria | 2 | 2015 | 21 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2004 | 4 | 0.060 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2004 | 21 | 0.060 |
Why?
|
| Cardiac Output | 3 | 1989 | 23 | 0.060 |
Why?
|
| Atenolol | 2 | 2003 | 2 | 0.060 |
Why?
|
| Carotid Stenosis | 1 | 2004 | 22 | 0.060 |
Why?
|
| Heart Murmurs | 1 | 1984 | 2 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2006 | 331 | 0.060 |
Why?
|
| Bioprosthesis | 1 | 1984 | 8 | 0.060 |
Why?
|
| Carotid Artery, Common | 1 | 2004 | 8 | 0.060 |
Why?
|
| Fluorocarbons | 1 | 2004 | 16 | 0.060 |
Why?
|
| Valsartan | 1 | 2004 | 2 | 0.060 |
Why?
|
| Homocysteine | 1 | 2004 | 8 | 0.060 |
Why?
|
| Tunica Media | 1 | 2004 | 15 | 0.060 |
Why?
|
| Heart Valve Prosthesis | 1 | 1984 | 21 | 0.060 |
Why?
|
| Albumins | 1 | 2004 | 35 | 0.060 |
Why?
|
| Forecasting | 2 | 2016 | 117 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 748 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2003 | 33 | 0.050 |
Why?
|
| Heart Function Tests | 2 | 2000 | 3 | 0.050 |
Why?
|
| Physician's Role | 1 | 2002 | 17 | 0.050 |
Why?
|
| Felodipine | 1 | 2001 | 1 | 0.050 |
Why?
|
| Blood Pressure Determination | 2 | 1992 | 21 | 0.050 |
Why?
|
| Age Factors | 2 | 2000 | 852 | 0.050 |
Why?
|
| Mississippi | 2 | 2016 | 3 | 0.050 |
Why?
|
| Manometry | 1 | 2001 | 20 | 0.050 |
Why?
|
| Assisted Circulation | 1 | 1981 | 4 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1981 | 6 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 1981 | 10 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 1992 | 221 | 0.050 |
Why?
|
| Thrombolytic Therapy | 2 | 2002 | 55 | 0.050 |
Why?
|
| Myocardial Revascularization | 2 | 2000 | 18 | 0.050 |
Why?
|
| Critical Illness | 1 | 2002 | 127 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2000 | 3 | 0.050 |
Why?
|
| Smoking | 2 | 2004 | 194 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 1999 | 22 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2000 | 39 | 0.040 |
Why?
|
| Pulse | 2 | 1996 | 6 | 0.040 |
Why?
|
| Body Weight | 1 | 2000 | 133 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 1247 | 0.040 |
Why?
|
| Emergencies | 2 | 1992 | 39 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2004 | 298 | 0.040 |
Why?
|
| Flecainide | 3 | 1994 | 14 | 0.040 |
Why?
|
| Creatine Kinase | 2 | 1997 | 33 | 0.040 |
Why?
|
| Clinical Enzyme Tests | 1 | 1997 | 2 | 0.040 |
Why?
|
| Sodium, Dietary | 1 | 1997 | 8 | 0.040 |
Why?
|
| Collateral Circulation | 1 | 1997 | 7 | 0.040 |
Why?
|
| Vascular Patency | 1 | 1997 | 14 | 0.040 |
Why?
|
| Patient Compliance | 2 | 1996 | 165 | 0.040 |
Why?
|
| Algorithms | 2 | 2002 | 400 | 0.040 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1997 | 5 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1997 | 54 | 0.040 |
Why?
|
| Periodicity | 1 | 1996 | 15 | 0.040 |
Why?
|
| Ventricular Premature Complexes | 1 | 1996 | 4 | 0.040 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1997 | 47 | 0.040 |
Why?
|
| Obesity | 3 | 2005 | 289 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 1997 | 77 | 0.030 |
Why?
|
| Diuretics | 1 | 1996 | 17 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 1997 | 90 | 0.030 |
Why?
|
| Lipids | 1 | 1996 | 36 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 1997 | 140 | 0.030 |
Why?
|
| Heart Arrest | 2 | 1994 | 59 | 0.030 |
Why?
|
| Recurrence | 1 | 1996 | 352 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2016 | 94 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 20 | 0.030 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1975 | 16 | 0.030 |
Why?
|
| Acetylglucosaminidase | 1 | 1994 | 5 | 0.030 |
Why?
|
| Heart Rate | 5 | 1995 | 152 | 0.030 |
Why?
|
| Safety | 1 | 1994 | 48 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2014 | 63 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 1997 | 1186 | 0.030 |
Why?
|
| Organ Size | 2 | 2004 | 107 | 0.030 |
Why?
|
| Pregnancy | 1 | 1975 | 388 | 0.030 |
Why?
|
| Natriuresis | 1 | 1993 | 3 | 0.030 |
Why?
|
| Wakefulness | 1 | 1993 | 80 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 1992 | 27 | 0.030 |
Why?
|
| Physicians' Offices | 1 | 1992 | 7 | 0.030 |
Why?
|
| Arteries | 1 | 1992 | 17 | 0.030 |
Why?
|
| Hypotension | 1 | 1992 | 27 | 0.030 |
Why?
|
| Heart Neoplasms | 1 | 1992 | 14 | 0.030 |
Why?
|
| Cats | 1 | 1992 | 75 | 0.030 |
Why?
|
| Dogs | 1 | 1992 | 261 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 812 | 0.020 |
Why?
|
| Blood Flow Velocity | 2 | 1989 | 20 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 3 | 1996 | 21 | 0.020 |
Why?
|
| Phonocardiography | 3 | 1984 | 3 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 1992 | 78 | 0.020 |
Why?
|
| Rabbits | 1 | 1992 | 283 | 0.020 |
Why?
|
| Anilides | 1 | 1991 | 10 | 0.020 |
Why?
|
| Fasting | 1 | 2011 | 13 | 0.020 |
Why?
|
| Acute Kidney Injury | 2 | 1989 | 49 | 0.020 |
Why?
|
| Encainide | 3 | 1994 | 7 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2004 | 970 | 0.020 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1988 | 3 | 0.020 |
Why?
|
| Tricuspid Valve Prolapse | 1 | 1988 | 2 | 0.020 |
Why?
|
| Tricuspid Valve | 1 | 1988 | 3 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 332 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1988 | 6 | 0.020 |
Why?
|
| Biomarkers | 2 | 2004 | 707 | 0.020 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1988 | 3 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2004 | 1126 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2001 | 640 | 0.020 |
Why?
|
| Hypertension, Malignant | 1 | 1986 | 1 | 0.020 |
Why?
|
| Neurologic Manifestations | 1 | 1986 | 1 | 0.020 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1986 | 2 | 0.020 |
Why?
|
| Auscultation | 1 | 1986 | 6 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 1986 | 7 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 1986 | 14 | 0.020 |
Why?
|
| Endocarditis, Bacterial | 1 | 1986 | 10 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2004 | 1462 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4941 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2004 | 6 | 0.020 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2004 | 2 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2004 | 30 | 0.020 |
Why?
|
| Cerebellum | 1 | 2005 | 52 | 0.020 |
Why?
|
| Young Adult | 1 | 2011 | 1966 | 0.020 |
Why?
|
| Postmenopause | 1 | 2004 | 61 | 0.020 |
Why?
|
| Cholesterol | 1 | 2004 | 54 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2004 | 15 | 0.010 |
Why?
|
| ROC Curve | 1 | 2004 | 140 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 230 | 0.010 |
Why?
|
| Survival Analysis | 2 | 1995 | 310 | 0.010 |
Why?
|
| Moricizine | 2 | 1994 | 6 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2005 | 118 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 101 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2004 | 346 | 0.010 |
Why?
|
| Child | 2 | 1986 | 1376 | 0.010 |
Why?
|
| Random Allocation | 2 | 1996 | 143 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 119 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 414 | 0.010 |
Why?
|
| Aging | 1 | 1993 | 1634 | 0.010 |
Why?
|
| Heart Sounds | 1 | 1981 | 1 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 225 | 0.010 |
Why?
|
| Death, Sudden | 1 | 1981 | 14 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2005 | 3325 | 0.010 |
Why?
|
| Cardiac Output, Low | 1 | 1981 | 3 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1981 | 55 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2002 | 151 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1986 | 957 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 319 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 1999 | 8 | 0.010 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 1999 | 5 | 0.010 |
Why?
|
| Syndrome | 1 | 1999 | 88 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1999 | 50 | 0.010 |
Why?
|
| Stents | 1 | 1999 | 76 | 0.010 |
Why?
|
| Acebutolol | 1 | 1997 | 1 | 0.010 |
Why?
|
| Chlorthalidone | 1 | 1997 | 1 | 0.010 |
Why?
|
| Amlodipine | 1 | 1997 | 3 | 0.010 |
Why?
|
| Libido | 1 | 1997 | 7 | 0.010 |
Why?
|
| Enalapril | 1 | 1997 | 4 | 0.010 |
Why?
|
| Orgasm | 1 | 1997 | 9 | 0.010 |
Why?
|
| Penile Erection | 1 | 1997 | 26 | 0.010 |
Why?
|
| Seasons | 1 | 1996 | 31 | 0.010 |
Why?
|
| Employment | 1 | 1996 | 42 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 147 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 1996 | 35 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1975 | 5 | 0.010 |
Why?
|
| Myoglobinuria | 1 | 1975 | 2 | 0.010 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1975 | 20 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 1995 | 29 | 0.010 |
Why?
|
| Postpartum Period | 1 | 1975 | 24 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1994 | 96 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1975 | 325 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1994 | 9 | 0.010 |
Why?
|
| Bias | 1 | 1993 | 34 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1993 | 24 | 0.010 |
Why?
|
| Eating | 1 | 1993 | 46 | 0.010 |
Why?
|
| Kidney | 1 | 1994 | 176 | 0.010 |
Why?
|
| Aspirin | 1 | 1994 | 84 | 0.010 |
Why?
|
| Adolescent | 2 | 1975 | 2331 | 0.010 |
Why?
|
| Minnesota | 1 | 1992 | 9 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1992 | 20 | 0.010 |
Why?
|
| Catheterization, Peripheral | 1 | 1992 | 15 | 0.010 |
Why?
|
| Software | 1 | 1992 | 72 | 0.010 |
Why?
|
| Equipment Design | 1 | 1992 | 185 | 0.010 |
Why?
|
| Linear Models | 1 | 1992 | 259 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1991 | 14 | 0.010 |
Why?
|
| Morbidity | 1 | 1991 | 63 | 0.010 |
Why?
|
| Labetalol | 1 | 1989 | 4 | 0.010 |
Why?
|
| Supination | 1 | 1989 | 19 | 0.010 |
Why?
|
| Thermodilution | 1 | 1989 | 6 | 0.010 |
Why?
|
| Time Factors | 1 | 1993 | 1640 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1989 | 50 | 0.000 |
Why?
|
| Angiography | 1 | 1988 | 39 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1987 | 143 | 0.000 |
Why?
|
| Angina Pectoris | 2 | 1976 | 18 | 0.000 |
Why?
|
| Calcinosis | 1 | 1981 | 48 | 0.000 |
Why?
|
| Bundle of His | 1 | 1981 | 32 | 0.000 |
Why?
|
| Methods | 1 | 1976 | 17 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1975 | 8 | 0.000 |
Why?
|
| Angiocardiography | 1 | 1975 | 1 | 0.000 |
Why?
|
| Pulmonary Artery | 1 | 1975 | 43 | 0.000 |
Why?
|
| Aspartate Aminotransferases | 1 | 1975 | 19 | 0.000 |
Why?
|
| Infant | 1 | 1975 | 542 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1975 | 654 | 0.000 |
Why?
|